Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, characterized by relatively selective death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). 6-Hydroxydopamine (6-OHDA), a neurotoxin that causes the death of DA neurons, is commonly used to produce experimental PD model in rodents. Accumulating evidences suggest that caspase-independent apoptotic programmed cell death (PCD) could also be involved in the progression of various neurodegenerative diseases in addition to caspase-dependent neuronal PCD. Apoptosis-inducing factor (AIF), a mitochondrial intermembrane oxidoreductase, has been identified as a key protein implicated in caspase-independent apoptosis. However, little is known about the role of AIF in death of nigral DA neurons in PD. Therefore, we undertook this study in an effort to clarify the involvement of AIF in DA neuronal death by 6-OHDA administration. Ten and twenty micrograms of 6-OHDA was infused into the medial forebrain bundle (MFB) unilaterally, and the experimental rats were sacrificed at various time point. The DA neuronal loss was identified in the ipsilateral SN in the dose-dependent manner by using NeuN and tyrosine hydroxylase immunohistochemical staining and western blot assay. Numerous degenerating neurons, showing apoptotic features which are characterized by the shrunken nuclei with eosinophilic perikarya were observed in the ipsilateral SNpc. Activating transcription factor 3 (ATF3), the specific marker for neuronal damage, was expressed in the ipsilateral DA neurons only. Immunohistochemistry and immunofluorescence staining demonstrated that nuclear localization of AIF in the ipsilateral degenerating DA neurons. These results suggest that AIF could induce DA neuronal death by caspase-independent apoptosis in 6-OHDA treated model, although other cell death cascades should not be rule out.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fahn, S. & Cohen, G. The oxidant stress hypothesis in Parkinson’s disease: evidence supporting it. Ann Neurol 32:804–812 (1992).
Ungerstedt, U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107–110 (1968).
Davis, G. C. et al. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1:249–254 (1979).
Curtius, H. C., Wolfensberger, M., Steinmann, B., Redweik, U. & Siegfried, J. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr 99:529–540 (1974).
Spencer, J. P. et al. Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71:2112–2122 (1998).
Stokes, A. H., Hastings, T. G. & Vrana, K. E. Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55:659–665 (1999).
Choi, W. S. et al. Two distinct mechanisms are involved in 6-hydroxydopamine-and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS and JNK. J Neurosci Res 57:86–94 (1999).
von Coelln, R. et al. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J Neurochem 77:263–273 (2001).
O’Malley, K. L., Liu, J., Lotharius, J. & Holtz, W. Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons. Neurobiol Dis 14:43–51 (2003).
Ebert, A. D., Hann, H. J. & Bohn, M. C. Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson’s disease does not involve activation of caspase-9 and caspase-3. J Neurosci Res 86:317–325 (2008).
Daugas, E. et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14:729–739 (2000).
Klein, J. A. et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 26:367–374 (2002).
Otera, H., Ohsakaya, S., Nagaura, Z., Ishihara, N. & Mihara, K. Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space. EMBO J 24:1375–1386 (2005).
Lorenzo, H. K., Susin, S. A., Penninger, J. & Kroemer, G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6:516–524 (1999).
Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441–446 (1999).
Susin, S. A. et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med 192:571–580 (2000).
Song, D. Y. et al. Axotomy-induced dopaminergic neurodegeneration is accompanied with c-Jun phosphorylation and activation transcription factor 3 expression. Exp Neurol 209:268–278 (2008).
Pu, H. et al. Heroin activates ATF3 and CytC via c-Jun N-terminal kinase pathways to mediate neuronal apoptosis. Med Sci Monit Basic Res 21:53–62 (2015).
Blum, D. et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65:135–172 (2001).
Glinka, Y. & Youdim, M. B. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol 292:329–332 (1995).
Sauer, H. & Oertel, W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401–415 (1994).
Lee, C. S., Sauer, H. & Bjorklund, A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72:641–653 (1996).
Dragunow, M. et al. Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? Brain Res Mol Brain Res 18:347–352 (1993).
Kawauchi, J. et al. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alphainduced apoptosis through down-regulation of p53 transcription. J Biol Chem 277:39025–39034 (2002).
Nakagomi, S., Suzuki, Y., Namikawa, K., Kiryu-Seo, S. & Kiyama, H. Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation. J Neurosci 23:5187–5196 (2003).
Park, S. H. et al. Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a noncanonical pathway under endoplasmic reticulum stress. J Biol Chem 289:27118–27133 (2014).
Song, D. Y. et al. Role of activating transcription factor 3 in ischemic penumbra region following transient middle cerebral artery occlusion and reperfusion injury. Neurosci Res 70:428–434 (2011).
Stadelmann, C. & Lassmann, H. Detection of apoptosis in tissue sections. Cell Tissue Res 301:19–31 (2000).
Huerta, S., Goulet, E. J., Huerta-Yepez, S. & Livingston, E. H. Screening and detection of apoptosis. J Surg Res 139:143–156 (2007).
Krantic, S., Mechawar, N., Reix, S. & Quirion, R. Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol 81:179–196 (2007).
Perier, C. et al. Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins. Ann Neurol 68:184–192 (2010).
Choi, W. S., Kruse, S. E., Palmiter, R. D. & Xia, Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci 105:15136–15141 (2008).
Jason, R., Cannon, J. & Timothy, G. The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases. Toxicol Sci 124:225–250 (2011).
Matthew, D. L., Terry, C. B., Alexander, A. M. & Purvesh, K. Integrated multi-cohort transcriptional metaanalysis of neurodegenerative diseases. Acta Neuropathol Commun 2:93 (2014).
LeBlanc, A. C. The role of apoptotic pathways in Alzheimer’s disease neurodegeneration and cell death. Curr Alzheimer Res 2:389–402 (2005).
Yu, W., Mechawar, N., Krantic, S. & Quirion, R. Evidence for the Involvement of Apoptosis-Inducing Factor-Mediated Caspase-Independent Neuronal Death in Alzheimer Disease. Am J Pathol 176:2209–2218 (2010).
Burguillos, M. A. et al. Apoptosis-inducing factor mediates dopaminergic cell death in response to LPSinduced inflammatory stimulus: evidence in Parkinson’s disease patients. Neurobiol Dis 41:177–188 (2011).
Kim, T. W. et al. Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson’s diseases. PLoS One 6:e25346 (2011).
Ma, C. et al. Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats. Life Sci 144:113–120 (2016).
Piao, C. S. et al. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Neurobiol Dis 46:745–758 (2012).
Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. Academic Press, San Diego (1998).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yoo, HI., Ahn, GY., Lee, EJ. et al. 6-Hydroxydopamine induces nuclear translocation of apoptosis inducing factor in nigral dopaminergic neurons in rat. Mol. Cell. Toxicol. 13, 305–315 (2017). https://doi.org/10.1007/s13273-017-0034-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-017-0034-5